Biotransformation of flumequine by the fungus Cunninghamella elegans.
The metabolism of the antibacterial fluoroquinolone drug flumequine by Cunninghamella elegans was investigated using cultures grown in Sabouraud dextrose broth with 308microM flumequine. The cultures were extracted with ethyl acetate; metabolites were separated by high-performance liquid chromatography and identified by mass spectrometry and proton nuclear magnetic resonance spectroscopy. Flumequine was transformed to two diastereomers of 7-hydroxyflumequine (23 and 43% of the total chromatographic peak area at 280nm) and 7-oxoflumequine (11% of the total peak area). This is the first time that the two 7-hydroxy diastereomers have been characterized structurally; the hydroxyflumequines are known to have less antimicrobial activity than flumequine.
Williams
Anna J
AJ
Division of Microbiology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA.
Deck
Joanna
J
Freeman
James P
JP
Paul Chiarelli
M
M
Adjei
Michael D
MD
Heinze
Thomas M
TM
Sutherland
John B
JB
D001711:Biotransformation; D020093:Cunninghamella / Q000378:metabolism*; D024841:Fluoroquinolones / Q000378:metabolism*; D012988:Soil Microbiology
D024841:Fluoroquinolones; C012976:flumequine